Document is current
Any future updates will be listed below
-
Authors
Slopis, John M.
Arevalo, Octavio
Bell, Cynthia S.
Hebert, Adelaide A.
Northrup, Hope
Riascos, Roy F.
Samuels, Joshua A.
Smith, Keri C.
Tate, Patti
Koenig, Mary Kay https://orcid.org/0000-0001-5126-8515
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02332902 at ClinicalTrials.govDocuments that mention this clinical trial
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial
https://doi.org/10.1007/s40268-018-0248-6
-
Funding
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (CRAD001CUS232T)
Texas Neurofibromatosis Foundation
- License Information
-
More Information
Article History
First Online: 3 October 2018
Compliance with Ethical Standards
:
: This study was supported by Novartis Pharmaceuticals (CRAD001CUS232T) and a research grant from the Texas Neurofibromatosis Foundation.
: John M. Slopis, Joshua A. Samuels, and Mary Kay Koenig report grants and personal fees from Novartis Pharmaceuticals. Keri C. Smith reports a grant from the Texas Neurofibromatosis Foundation. Joshua A. Samuels reports personal fees from MedStudy, Inc. Adelaide A. Hebert, Hope Northrup, and Mary Kay Koenig report provisional patents pending. John M. Slopis is employed by The University of Texas MD Anderson Cancer Center. Octavio Arevalo, Adelaide A. Hebert, Hope Northrup, Riascos, Joshua A. Samuels, Keri C. Smith, Mary Kay Koenig, Cynthia S. Bell, and Patti Tate are or were employed by The University of Texas Health Science Center at Houston at the time of this trial.
: All data generated or analyzed during this study are included in this published article and the Electronic Supplementary Material.
: The study protocol along with consent forms were reviewed and approved by the Committee for the Protection of Human Subjects at the University of Texas Health Science Center at Houston (HSC-MS-14-0758).
: All subjects consented to participate in this study.
